| 1428 |
National Cancer Institute |
Html |
null |
Retinoblastoma Treatment (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the treatment of retinoblastoma in children. |
|
|
CLICK HERE |
| 1595 |
National Cancer Institute |
Html |
en |
Gastric Cancer Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of gastric cancer. |
| treatment | 0.591238 |
| cancer treatment | 0.450405 |
| gastric cancer cells | 0.441573 |
| Gastric Cancer Treatment | 0.444726 |
| NCI-supported cancer | 0.4391 |
| stomach | 0.735063 |
| cancer cells | 0.582767 |
| malignant tumor cells | 0.419107 |
| body | 0.442061 |
| Cancer Information Service | 0.403362 |
| PDQ cancer information | 0.496418 |
| specific cancer cells | 0.40594 |
| HER2-positive gastric cancer | 0.441612 |
| clinical trial search | 0.508645 |
| stomach wall | 0.679257 |
| treatment clinical trials | 0.435225 |
| National Cancer Institute | 0.459181 |
| clinical trials | 0.857251 |
| nearby lymph nodes | 0.422969 |
| cancer information summary | 0.459638 |
| clinical trial | 0.69582 |
| gastric cancer spreads | 0.435883 |
| new treatment | 0.430993 |
|
| gastric cancer | 0.961916 |
| recurrent gastric cancer | 0.423214 |
| ) layer. | 0.427318 |
| stomach disease | 0.413534 |
| patients | 0.40139 |
| metastatic gastric cancer | 0.437702 |
| Stomach pain | 0.405557 |
| NCI PDQ cancer | 0.415126 |
| cancer clinical trials | 0.531962 |
| lymph nodes | 0.644979 |
| stage | 0.470953 |
| stomach cancer | 0.464876 |
| tumor | 0.483246 |
| chemoradiation therapy | 0.469475 |
| radiation therapy | 0.455319 |
| Treatment Editorial Board | 0.403905 |
| cancer information summaries | 0.401354 |
| stomach discomfort | 0.411852 |
| information | 0.507295 |
| small intestine | 0.476652 |
| subtotal gastrectomy | 0.452908 |
| monoclonal antibody | 0.404834 |
| General information | 0.405606 |
|
CLICK HERE |
| 1657 |
National Cancer Institute |
Html |
en |
Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the treatment of childhood medulloblastoma, nonmedulloblastoma embryonal tumors, and pineal tumors. |
| adjuvant chemotherapy | 0.284178 |
| primitive neuroectodermal tumors | 0.441731 |
| Low-stage medulloblastoma | 0.276631 |
| standard risk medulloblastoma | 0.295812 |
| craniospinal radiation therapy | 0.289613 |
| prognostic factors | 0.298331 |
| chemotherapy | 0.308667 |
| high-risk disseminated medulloblastoma | 0.295264 |
| medulloblastoma extent | 0.319739 |
| metastatic medulloblastoma | 0.292959 |
| early childhood medulloblastoma | 0.501191 |
| brain tumors | 0.331694 |
| children | 0.47617 |
| von Bueren AO | 0.264775 |
| young children | 0.341987 |
| Cancer Group | 0.327468 |
| Radiat Oncol Biol | 0.296868 |
| WNT medulloblastoma cases | 0.313174 |
| medulloblastoma | 0.767685 |
| nonmedulloblastoma embryonal tumors | 0.263341 |
| medulloblastoma subgroups | 0.365378 |
| paediatric medulloblastoma | 0.27996 |
| von Hoff | 0.292117 |
| desmoplastic/nodular medulloblastoma | 0.301127 |
| desmoplastic medulloblastoma | 0.355762 |
|
| syndrome-associated childhood medulloblastoma | 0.323686 |
| medulloblastoma patients | 0.341131 |
| Clin Cancer Res | 0.271749 |
| radiation therapy | 0.321079 |
| Acta Neuropathol | 0.331155 |
| et al. | 0.786797 |
| Pediatr Blood Cancer | 0.60557 |
| pineal gland cyst | 0.276571 |
| medulloblastoma resection | 0.293465 |
| standard-risk medulloblastoma | 0.318484 |
| average-risk medulloblastoma | 0.337894 |
| Medulloblastoma variants | 0.320092 |
| Abstract | 0.770373 |
| Clin Oncol | 0.950195 |
| pediatric medulloblastoma | 0.392703 |
| Oncol Biol Phys | 0.298432 |
| embryonal tumors | 0.349688 |
| medulloblastoma resections | 0.29489 |
| nonmetastatic medulloblastoma | 0.294586 |
| embryonal brain tumors | 0.299215 |
| newly diagnosed medulloblastoma | 0.289358 |
| medulloblastoma subtypes | 0.331966 |
| complexity underlying medulloblastoma | 0.308738 |
| WNT medulloblastoma tumors | 0.354112 |
|
CLICK HERE |
| 1753 |
National Cancer Institute |
Html |
en |
Hormone Therapy for Breast Cancer |
A fact sheet that describes types of hormone therapy, its role in preventing and treating breast cancer, and possible side effects. |
| Surgical Adjuvant Breast | 0.492707 |
| estrogen | 0.502159 |
| primary breast cancer | 0.489122 |
| early-stage ER-positive breast | 0.480551 |
| aromatase inhibitors anastrozole | 0.480936 |
| ER-positive early-stage breast | 0.480383 |
| aromatase inhibitors | 0.525562 |
| breast cancer subtypes | 0.491642 |
| metastatic ER-positive breast | 0.481109 |
| early-stage breast cancer | 0.616245 |
| tamoxifen | 0.550216 |
| breast cancer hormone | 0.522198 |
| ER-positive breast cancer | 0.553345 |
| breast cancer prevention | 0.522495 |
| breast cancer patients | 0.511592 |
| postmenopausal breast cancer | 0.509489 |
| new breast cancer | 0.500245 |
| adjuvant hormone therapy | 0.504935 |
| estrogen receptors | 0.483294 |
| HR-positive breast cancer | 0.521679 |
| hormone receptor-positive breast | 0.501962 |
| metastatic breast cancer | 0.52726 |
| invasive breast cancer | 0.511911 |
| early breast cancer | 0.587772 |
|
| breast cancer cells | 0.575964 |
| breast cancer recurrence | 0.50934 |
| breast cancers | 0.514423 |
| ER-positive breast cancers | 0.488424 |
| premenopausal women | 0.499525 |
| National Cancer Institute | 0.500748 |
| IBIS-I breast cancer | 0.488534 |
| hormone therapy | 0.718328 |
| hormone-sensitive breast cancer | 0.587411 |
| breast tumors | 0.505842 |
| postmenopausal women | 0.702436 |
| breast cancer risk | 0.498557 |
| International Breast Cancer | 0.496186 |
| Letrozole Breast Cancer | 0.491109 |
| estrogen receptor | 0.488845 |
| advanced hormone-sensitive breast | 0.480069 |
| receptor–positive breast cancer | 0.52072 |
| breast cancer | 0.988243 |
| Breast Cancer Trialists | 0.51995 |
| adjuvant tamoxifen | 0.489054 |
| tamoxifen treatment | 0.48115 |
| hormone receptor–positive breast | 0.534822 |
| et al | 0.566786 |
| advanced breast cancer | 0.554835 |
|
CLICK HERE |
| 1854 |
National Cancer Institute |
Html |
es |
Tratamiento del melanoma ocular uveal (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento del melanoma ocular uveal. |
| Lippincott Williams | 0.0202121 |
| Compton CC | 0.0326793 |
| intraocular melanoma | 0.187253 |
| Singh AD | 0.0183835 |
| mortality findings | 0.0177193 |
| initial mortality findings | 0.0168176 |
| Collaborative Ocular Melanoma | 0.845271 |
| tumores coroideos | 0.0533438 |
| concerning uveal melanomas | 0.0413676 |
| transformation into melanoma | 0.0471527 |
| 7th ed | 0.0334776 |
| melanoma intraocular uveal | 0.0617166 |
| transpupillary thermotherapy | 0.0364759 |
| choroidal melanoma | 0.885011 |
| Ophthalmol Clin | 0.0328664 |
| melanoma coroideo | 0.351056 |
| Radiat Oncol Biol | 0.049169 |
| DeVita VT Jr | 0.0170972 |
| coms report | 0.12083 |
| Iris melanomas | 0.0424181 |
| choroidal melanoma ii | 0.0483613 |
| small choroidal melanoma | 0.146057 |
| from intraocular melanoma | 0.0447667 |
| metastatic melanoma | 0.0397711 |
| Ocular Melanoma Study | 0.837498 |
|
| Shields JA | 0.126368 |
| Diffuse choroidal melanoma | 0.048527 |
| COMS randomized | 0.0359843 |
| melanomas coroideos | 0.0974806 |
| uveal melanomas | 0.9898 |
| Melanoma Study Group | 0.158608 |
| Malignant melanoma | 0.12436 |
| from uveal melanoma | 0.0570651 |
| Cancer Staging Manual | 0.0611746 |
| uveal melanoma management | 0.0496842 |
| COMS Medium Tumor | 0.0243028 |
| Arch Ophthalmol | 0.4179 |
| large choroidal melanoma | 0.0789386 |
| New York | 0.0440447 |
| cLos melanomas | 0.0368816 |
| Diener-West M | 0.0182158 |
| large uveal melanomas | 0.0943176 |
| Oncol Biol Phys | 0.0503576 |
| malignant uveal melanoma | 0.051425 |
| unrecognized choroidal melanoma | 0.0480539 |
| Byrd DR | 0.0304967 |
| Shields CL | 0.154709 |
| Int Ophthalmol Clin | 0.0287474 |
| AJCC Cancer Staging | 0.0646958 |
|
CLICK HERE |
| 1869 |
National Cancer Institute |
Html |
es |
Tratamiento del sarcoma de tejido blando infantil (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento del sarcoma de tejido blando infantil. |
| Pediatric Oncology | 0.427738 |
| Childhood soft tissue | 0.412657 |
| Sarcoma Group | 0.408529 |
| soft part sarcoma | 0.421702 |
| Pediatr Surg Int | 0.410488 |
| tumor >5 cm | 0.40873 |
| Neonatal soft tissue | 0.41137 |
| pediatric nonrhabdomyosarcoma soft | 0.423413 |
| soft-tissue sarcoma | 0.42357 |
| oncology group study | 0.42018 |
| sarcoma necessary after | 0.409292 |
| Children's Oncology Group | 0.423153 |
| sarcoma results | 0.408962 |
| undifferentiated sarcoma | 0.409416 |
| 5th ed | 0.408863 |
| pediatric soft tissue | 0.468096 |
| Weiss's Soft Tissue | 0.465072 |
| soft tissue sarcoma | 0.984779 |
| low-grade fibromyxoid sarcoma | 0.417727 |
| Jude Children Research | 0.411214 |
| lower extremity sarcomas | 0.408827 |
| nonrhabdomyosarcoma soft | 0.450499 |
| sarcoma patients | 0.409132 |
| End Results | 0.409463 |
| Surg Pathol | 0.410619 |
|
| cuello sarcoma | 0.408715 |
| Ferrari A | 0.410275 |
| Pediatr Blood Cancer | 0.449691 |
| Cancer Staging Manual | 0.440273 |
| Weiss SW | 0.438749 |
| Genes Chromosomes Cancer | 0.409368 |
| Translocation-related sarcomas | 0.408627 |
| Surg Oncol | 0.422483 |
| Adult-type soft tissue | 0.411539 |
| Sarcomas embrionarios | 0.408595 |
| Pediatr Surg | 0.44479 |
| part sarcoma fuses | 0.409332 |
| Clin Oncol | 0.434253 |
| Children's Research Hospital | 0.410798 |
| Goldblum JR | 0.438633 |
| sarcomas with surgery | 0.409572 |
| soft tissue tumors | 0.508399 |
| Pediatric Oncology Group | 0.420884 |
| >5 cm | 0.415115 |
| retroperitoneo sarcoma | 0.408795 |
| round cell tumor | 0.41657 |
| Oncology Group | 0.440064 |
| localized soft-tissue sarcomas | 0.40921 |
| AJCC Cancer Staging | 0.461396 |
|
CLICK HERE |
| 2066 |
National Cancer Institute |
Html |
es |
Los cuidados al final de la vida de personas con cáncer |
Hoja informativa que responde algunas de las preguntas que tienen muchos pacientes, sus familiares y quienes cuidan de ellos acerca del final de la vida. |
| desechos quizás | 0.586339 |
| pequeñas porciones | 0.540804 |
| alcance objetos | 0.559532 |
| suficientes glóbulos | 0.562578 |
| causa hinchazón | 0.558057 |
| dosis correctos | 0.546349 |
| médicos cuánto tiempo | 0.63336 |
| suficiente oxÃgeno | 0.652738 |
| cuánto tiempo | 0.903324 |
| suficiente tejido | 0.550065 |
| paciente experimenta sÃntomas | 0.986626 |
| paciente quizás | 0.789052 |
| considerable agitación | 0.540843 |
| quizás querrán | 0.579319 |
|
| menor flujo | 0.542617 |
| presente somnolencia | 0.544492 |
| reducida capacidad | 0.540414 |
| persona enferma causa | 0.731054 |
| malos dÃas | 0.539357 |
| mejores cuidadores | 0.583437 |
| Mayor debilidad | 0.544974 |
| falsas esperanzas | 0.572246 |
| siguientes situaciones | 0.566454 |
| cuerpo boca | 0.542456 |
| familia esté lista | 0.658292 |
| paciente presente incontinencia | 0.756496 |
| persona quizás | 0.668635 |
|
CLICK HERE |
| 3455 |
National Cancer Institute |
Html |
es |
Acupuntura (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos sobre la acupuntura como tratamiento para las personas con cáncer o trastornos relacionados con esta enfermedad. |
| Zhang G | 0.32606 |
| chinese herbs | 0.319163 |
| Niemtzow RC | 0.320654 |
| Ghaly RG | 0.32227 |
| cáncer gástrico grupo | 0.319634 |
| splenic natural killer | 0.318671 |
| consecutivos dolor | 0.340228 |
| acupuntura versus | 0.39936 |
| Pharmacol Biochem Behav | 0.321201 |
| Yang J | 0.320136 |
| cáncer grupo | 0.365962 |
| ECA Dolor | 0.328485 |
| Chinese Acupuncture | 0.324024 |
| traditional chinese | 0.334765 |
| Estados Unidos | 0.464193 |
| Oriental Medicine | 0.333741 |
| Zhongguo Zhong Xi | 0.337599 |
| its regulative function | 0.324075 |
| Med Hist | 0.316569 |
| Mod Med Asia | 0.316861 |
| Zhong Xi Yi | 0.336593 |
| Pain Symptom Manage | 0.370153 |
| Xi Yi Jie | 0.336643 |
| Altern Complement Med | 0.372332 |
| Complement Ther Med | 0.320059 |
|
| Hand Acupuncture Therapy | 0.319232 |
| killer cell cytotoxicity | 0.32019 |
| Acupuncture techniques | 0.319086 |
| Curr Probl Cancer | 0.317979 |
| acupuntura guanyuan | 0.365152 |
| Tradit Chin Med | 0.903597 |
| alternative medicine | 0.411597 |
| Churchill Livingstone | 0.334944 |
| Dundee JW | 0.395667 |
| New York | 0.354273 |
| Soc Med | 0.364691 |
| systematic review | 0.333425 |
| cáncer óseo | 0.319179 |
| Zhang RX | 0.320688 |
| Acupuncture stimulation enhances | 0.344465 |
| acupuntura mejora | 0.364667 |
| treated with | 0.328504 |
| Desconocida SÃ | 0.317149 |
| chinese medicine | 0.449414 |
| Za Zhi | 0.321785 |
| Acupuncture prophylaxis | 0.318487 |
| Liu B | 0.317806 |
| stimulation enhances splenic | 0.322832 |
| Fitzpatrick KT | 0.320501 |
|
CLICK HERE |
| 3598 |
National Cancer Institute |
Html |
en |
Childhood Cancer Survivor Study: An Overview |
Health problems that develop years later as a result of a cancer treatment are known as late effects. The Childhood Cancer Survivor Study (CCSS) was started in 1994 to better understand these late effects. |
| Cancer Survivor Study | 0.651761 |
| Clinical Oncology | 0.430017 |
| childhood cancer | 0.933179 |
|
| journal article | 0.545579 |
| childhood cancer survivor | 0.797555 |
|
CLICK HERE |
| 14596 |
National Cancer Institute |
Html |
en |
What Is Cancer? |
Explanations about what cancer is, how cancer cells differ from normal cells, and genetic changes that cause cancer to grow and spread. |
| benign brain tumors | 0.40676 |
| star-shaped brain cells | 0.473891 |
| human cells | 0.482443 |
| nearby normal cells | 0.498609 |
| squamous cells | 0.495031 |
| body’s cells | 0.493774 |
| tumor suppressor genes | 0.441927 |
| white blood cells | 0.5174 |
| malignant tumors | 0.410135 |
| Reed-Sternberg cells | 0.446673 |
| abnormal plasma cells | 0.47073 |
| tissues | 0.391204 |
| epithelial cell types | 0.372838 |
| extra cells | 0.532701 |
| blood vessels | 0.389179 |
| nerve cells | 0.450383 |
| solid tumors | 0.421449 |
| DNA repair genes | 0.397134 |
| Metastatic tumors | 0.385874 |
| carcinoid tumors | 0.394635 |
| metastatic breast cancer | 0.390046 |
| cancers | 0.429846 |
| immune system cells | 0.472603 |
| myeloma cells | 0.447313 |
| soft tissue sarcoma | 0.382156 |
|
| neuroendocrine tumors | 0.396625 |
| different cells | 0.465518 |
| abnormal cells | 0.497795 |
| metastatic cancer cells | 0.542261 |
| cancer cells | 0.711115 |
| normal blood cells | 0.520987 |
| unneeded cells | 0.469669 |
| new cells | 0.509463 |
| squamous cell | 0.373428 |
| normal cells | 0.564574 |
| types | 0.419663 |
| epithelial cells | 0.524359 |
| Cancerous tumors | 0.382835 |
| genetic changes | 0.400724 |
| tumors | 0.551639 |
| germ cell tumors | 0.421823 |
| cells | 0.91549 |
| new tumors | 0.381387 |
| benign tumors | 0.426682 |
| damaged cells | 0.483579 |
| cells function | 0.467145 |
| cancer | 0.716841 |
| leukemia cells | 0.447258 |
| spinal cord tumors | 0.44102 |
|
CLICK HERE |